Shares of Ocugen Inc. /zigman2/quotes/208160861/composite OCGN +5.72% shed 4.37% to $8.53 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.08% falling 0.82% to 4,646.71 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.56% falling 0.66% to 36,079.94. This was the stock's third consecutive day of losses. Ocugen Inc. closed $10.24 below its 52-week high ($18.77), which the company reached on February 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Adverum Biotechnologies Inc. /zigman2/quotes/210484271/composite ADVM +3.13% fell 1.30% to $2.27, Ocular Therapeutix Inc. /zigman2/quotes/207607068/composite OCUL +0.65% fell 5.24% to $7.23, and Kodiak Sciences Inc. /zigman2/quotes/207655028/composite KOD +3.68% fell 5.14% to $111.73. Trading volume (25.9 M) remained 10.8 million below its 50-day average volume of 36.7 M.